Celularity (CELUW) Shares Outstanding (Diluted Average) (2021 - 2025)

Celularity (CELUW) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $25.6 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $25.6 million, up 16.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $25.6 million (up 16.94% YoY), and the FY2025 annual result was $25.6 million, up 16.94% from the prior year.
• Shares Outstanding (Diluted Average) eased to $25.6 million in Q4 2025 per CELUW's latest filing, from $26.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $151.3 million in Q2 2022 and troughed at $15.5 million in Q1 2023.
• A 5-year average of $37.4 million and a median of $21.9 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) jumped 530.7% in 2022, then plunged 89.03% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $24.0 million in 2021, then jumped by 530.7% to $151.3 million in 2022, then sank by 88.23% to $17.8 million in 2023, then grew by 22.89% to $21.9 million in 2024, then increased by 16.94% to $25.6 million in 2025.
• Business Quant data shows CELUW's Shares Outstanding (Diluted Average) at $25.6 million in Q4 2025, $26.3 million in Q3 2025, and $24.0 million in Q2 2025.